ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

FGFBP1 as a potential biomarker predicting bacillus Calmette-Guerin response in bladder cancer

Li, Fei; Zhang, Henghui; Wang, Yu; Yao, Zhihao; Xie, Kunfeng; Mo, Qixin; Fan, Qin; Hou, Lina*; Deng, Fan*; Tan, Wanlong*南方医科大学
Frontiers in Immunology2022-9-2DOI: 10.3389/fimmu.2022.954836
7被引9阅读
引用收藏
分享

摘要

Accurate prediction of Bacillus Calmette-Guerin (BCG) response is essential to identify bladder cancer (BCa) patients most likely to respond sustainably, but no molecular marker predicting BCG response is available in clinical routine. Therefore, we first identified that fibroblast growth factor binding protein 1 (FGFBP1) was upregulated in failures of BCG therapy, and the increased FGFBP1 had a poor outcome for BCa patients in the E-MTAB-4321 and GSE19423 datasets. These different expression genes associated with FGFBP1 expression are mainly involved in neutrophil activation, neutrophil-mediated immunity, and tumor necrosis factor-mediated signal pathways in biological processes. A significant positive correlation was observed between FGFBP1 expression and regulatory T-cell (Treg) infiltration by the Spearman correlation test in the BCG cohort (r = 0.177) and The Cancer Genome Atlas (TCGA) cohort (r = 0.176), suggesting that FGFBP1 may influence the response of BCa patients to BCG immunotherapy through immune escape. Though FGFBP1 expression was positively correlated with the expressions of PD-L1, CTLA4, and PDCD1 in TCGA cohort, a strong association between FGFBP1 and PD-L1 expression was only detected in the BCG cohort (r = 0.750). Furthermore, elevated FGFBP1 was observed in BCa cell lines and tissues in comparison to corresponding normal controls by RT-qPCR, Western blotting, and immunohistochemical staining. Increased FGFBP1 was further detected in the failures than in the responders by immunohistochemical staining. Notably, FGFBP1 is positively associated with PD-L1 expression in BCa patients with BCG treatment. To sum up, FGFBP1 in BCa tissue could be identified as a promising biomarker for the accurate prediction of BCG response in BCa.

学科与关键词

关键词
bladder cancerbacillus Calmette-GuerinFGFBP1biomarkerPD-L1
相关
加载中…
  • Identification of tumor microenvironment-related signature for predicting prognosis and immunotherapy response in patients with bladder cancer
    Yao, Zhihao; Zhang, Henghui; Zhang, Xuejun; Zhang, Zhiyong; Jie, Jirong; Xie, Kunfeng; Li, Fei*; Tan, Wanlong*Frontiers in Genetics, 2022, 13: 923768.被引 1
  • A candidate prognostic biomarker: TFEB inhibits tumor progression via elevating CDKN1A in bladder cancer
    Yue, Minghao; Yang, Zhe; Sun, Jiabin; Liu, Zan*International Immunopharmacology, 2023, 125: 111016.
  • Urogenital Microbiota:Potentially Important Determinant of PD-L1 Expression in Male Patients with Non-muscle Invasive Bladder Cancer
    Chen, Chunxiao; Huang, Zehai; Huang, Pengcheng; Li, Kun; Zeng, Jiarong; Wen, Yuehui; Li, Biao; Zhao, Jie*; Wu, Peng*BMC MICROBIOLOGY, 2022, 22(1): 7.被引 13
查看全部 →

发表信息

论文状态
公开发表
期刊
Frontiers in Immunology
发表日期
2022-09-02
卷期
第 13 卷
页码
954836
DOI
10.3389/fimmu.2022.954836
语言
ENGLISH
期刊等级
2区
成果收录
SCIE
资助标注
Natural Science Foundation Committee of China [NSFC 82073162]; Natural Science Foundation of Guangdong Province of China [2021A1515010762]; Outstanding Youth Development Scheme of Nanfang Hospital, Southern Medical University [2019J009]; Dean's research fund of Nanfang Hospital, the Southern Medical University [2020Z005, 2019B008]; Beijing Bethune Charitable Foundation [mnzl202017]

作者

  • L

    Li, Fei (第一作者)

    southern med univ

  • Z

    Zhang, Henghui

    southern med univ

查看全部 10 位作者收起作者
  • W

    Wang, Yu

    southern med univ

  • Y

    Yao, Zhihao

    southern med univ

  • X

    Xie, Kunfeng

    southern med univ

  • M

    Mo, Qixin

    southern med univ

  • F

    Fan, Qin

    southern med univ

  • H

    Hou, Lina (通讯)

    southern med univ

  • D

    Deng, Fan (通讯)

    southern med univ

  • T

    Tan, Wanlong (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417